CARDINAL HEALTH INC · Drugs, Proprietaries & Druggists' Sundries

CAH

Low riskNext report: In 2 days (est.)

View price ↗

The short version

A profitable company with growing sales. Institutions are adding.

Going well

Sales up 19% in the latest quarter vs a year ago
Profitable
Brings in more cash than it spends

Money moves

No insider buying or selling in the last 30 days
Institutions added 2.7% to their holdings in the quarter ending June 2026 (676 bought, 649 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$251.59+0.8% that day

Company value: $58.5B; Share price times all shares
Price vs profit (P/E): 37.5x; You pay about $37 for each $1 of yearly profit
Price vs sales: 0.24x; Company value is 0.24 times a year of sales
Dividend yield: 0.8%; Yearly dividend as a share of today's price
Cash vs value: 5%; Cash as a share of company value
Debt vs value: 14%; Debt as a share of company value

From CAH's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Dec '25

$65.6B+19% vs a year earlier

Mar '23Tap a barDec '25

Last 12 months: $244.7B, up 10% from the 12 months before. Over 5 years, sales grew about 7.8% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of CAH. Starting points are the company's recent numbers.

Sales growth+10% a yearRecently: +10% a yearProfit margin1%Last 12 months: 0.7%P/E at the end37xToday: 37.5x. Many steady companies trade at 12x to 25xShare count change-4% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$394.0B

Profit in 5 years$3.9B

Price these guesses point to$768.83+206% vs $251.59 todayAbout +25% a year, before dividends

What today's price needs: with a 1% margin and a 37x P/E, sales could shrink about 12% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

2/6Weak

MissDebt under half of equityNot relying on borrowed money.Owes more than it owns
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.0.7%
MissProfitable every yearSteady profits, not one good year.8 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$1.9B
PassShare count not growingNot diluting owners. Falling means buybacks.-13.3% in 3 years
MissGross margin 40%+Pricing power: sells for well above what it costs to make.3.7%

Revenue: $222.6B; -1.9% vs prior year
5-year growth: +7.8%/yr; revenue, per year
Total debt: $8.3B
Current ratio: 0.91x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Dec 31, 2025

Reported Aug 11

Revenue: $65.6B; +18.8% YoY
Op. margin: 1.1%; +0.1 pts
Gross margin: 3.7%; +0.2 pts
Free cash flow: $555.0M
Share count: -2.5%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 3.0
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+2.7%

Institutions added 2.7% to their holdings. 676 bought, 649 sold.

Shares held by institutions206.3M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-2.5%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

Owes more than it owns

Shares outstandingLatest reported

233M

Earnings reports

Last 12

Next reportIn 2 days (est.)Estimated from the same quarter last year

Results filedAug 11
Results filedApr 30
Results filedFeb 5
Results filedOct 30, 2025
Results filedAug 12, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

New 5%+ holder (passive)Aug 13 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

Investor disclosureOct 1 · Form 8-K ↗Proxy statementSep 21 · Form DEF 14A ↗DEFA14ASep 21 · Form DEFA14A ↗ARSSep 21 · Form ARS ↗

SoldMichelle D. GreeneChief Information Officer

11,650 shares at $235.72 avg ($234.57 to $237.25) · $2.7M

-53% of holdings
Now owns 10,330 shares
Not a pre-planned sale
4 transactions
Filed 2 days after trade

Aug 18Form 4 ↗

SoldJessica L MayerChief Legal/Compliance Officer

29,436 shares at $236.19 avg ($234.64 to $237.31) · $7.0M

-47% of holdings
Now owns 33,076 shares
Not a pre-planned sale
4 transactions
Filed 2 days after trade

Aug 18Form 4 ↗

SoldAaron E AltChief Financial Officer

42,000 shares at $236.34 avg ($234.55 to $237.26) · $9.9M

-67% of holdings
Now owns 20,495 shares
Not a pre-planned sale
4 transactions
Filed 2 days after trade

Aug 18Form 4 ↗

SoldDeborah WeitzmanCEO, PSS Segment

7,354 shares at $235.45 avg ($235.30 to $237.44) · $1.7M

-9% of holdings
Now owns 77,901 shares
Not a pre-planned sale
3 transactions
Filed 2 days after trade

Aug 18Form 4 ↗

SoldStephen M MasonCEO, GMPD Segment

35,000 shares at $236.40 avg ($234.59 to $237.26) · $8.3M

-66% of holdings
Now owns 18,061 shares
Not a pre-planned sale
4 transactions
Filed 2 days after trade

Aug 18Form 4 ↗

SoldJason M. HollarChief Executive Officer

124,529 shares at $235.89 avg ($233.22 to $237.88) · $29.4M

-40% of holdings
Now owns 190,603 shares
Not a pre-planned sale
10 transactions
Filed 1 day after trade

Aug 19Form 4 ↗

Insider tradeAug 20 · Form 4 ↗Planned insider saleAug 19 · Form 144 ↗Insider tradeAug 18 · Form 4 ↗Insider tradeAug 18 · Form 4 ↗Insider tradeAug 18 · Form 4 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page